[go: up one dir, main page]

GB201916186D0 - Biomarkers for aiding in the diagnosis of mental disorders - Google Patents

Biomarkers for aiding in the diagnosis of mental disorders

Info

Publication number
GB201916186D0
GB201916186D0 GBGB1916186.8A GB201916186A GB201916186D0 GB 201916186 D0 GB201916186 D0 GB 201916186D0 GB 201916186 A GB201916186 A GB 201916186A GB 201916186 D0 GB201916186 D0 GB 201916186D0
Authority
GB
United Kingdom
Prior art keywords
biomarkers
aiding
diagnosis
mental disorders
mental
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1916186.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Randox Laboratories Ltd
Original Assignee
Randox Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Randox Laboratories Ltd filed Critical Randox Laboratories Ltd
Priority to GBGB1916186.8A priority Critical patent/GB201916186D0/en
Publication of GB201916186D0 publication Critical patent/GB201916186D0/en
Priority to PCT/EP2020/081272 priority patent/WO2021089771A1/en
Priority to EP20807296.7A priority patent/EP4055390A1/en
Ceased legal-status Critical Current

Links

GBGB1916186.8A 2019-11-07 2019-11-07 Biomarkers for aiding in the diagnosis of mental disorders Ceased GB201916186D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB1916186.8A GB201916186D0 (en) 2019-11-07 2019-11-07 Biomarkers for aiding in the diagnosis of mental disorders
PCT/EP2020/081272 WO2021089771A1 (en) 2019-11-07 2020-11-06 Biomarkers for aiding in the diagnosis of mental disorders
EP20807296.7A EP4055390A1 (en) 2019-11-07 2020-11-06 Biomarkers for aiding in the diagnosis of mental disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1916186.8A GB201916186D0 (en) 2019-11-07 2019-11-07 Biomarkers for aiding in the diagnosis of mental disorders

Publications (1)

Publication Number Publication Date
GB201916186D0 true GB201916186D0 (en) 2019-12-25

Family

ID=69062096

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1916186.8A Ceased GB201916186D0 (en) 2019-11-07 2019-11-07 Biomarkers for aiding in the diagnosis of mental disorders

Country Status (3)

Country Link
EP (1) EP4055390A1 (en)
GB (1) GB201916186D0 (en)
WO (1) WO2021089771A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9800655A (en) 1997-04-21 1999-08-10 Randox Lab Ltd Solid state device for performing assays with multiple analyzed its use and and system for analyzing multiple analyzed
US9249467B2 (en) * 2011-09-16 2016-02-02 Steven Goodison Bladder cancer detection composition, kit and associated methods
WO2016160484A1 (en) * 2015-03-27 2016-10-06 Myriad Genetics, Inc. Novel biomarkers for psychiatric disorders

Also Published As

Publication number Publication date
EP4055390A1 (en) 2022-09-14
WO2021089771A1 (en) 2021-05-14

Similar Documents

Publication Publication Date Title
IL270864A (en) Detection of biomarkers on vesicles for the diagnosis and prognosis of diseases and disorders
IL277272A (en) Rimegepant for cgrp related disorders
GB2542155B (en) Use of cannabidiol in the treatment of mental disorders
LT3481846T (en) 11-substituted 24-hydroxysterols for use in the treatment of nmda related conditions
EP3284830A4 (en) Biomarker for mental disease
PL3377909T3 (en) Lactoferrin for use in the diagnosis or prognosis of alzheimer's disease
EP3256859A4 (en) A biomarker for diagnosing vascular diseases and the uses thereof
PL3484475T3 (en) 1-methylnicotinamide for the treatment of cardiovascular disease
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
IL283031A (en) Vibegron for the treatment of overactive bladder symptoms
EP3096775A4 (en) Socs mimetics for the treatment of diseases
EP3109636A4 (en) Biomarker for parkinson's disease and use therefor
GB201619808D0 (en) Biomarkers for the prognosis and diagnosis of cancer
SG11201706249RA (en) Biomarkers for diagnosis and prognosis of corneal ectatic disorders
IL284032A (en) 3β-(benzyloxy)-17α-methyl-pregn-5-en-20-one for use in the treatment of cognitive disorders
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
GB201916186D0 (en) Biomarkers for aiding in the diagnosis of mental disorders
PL3829599T3 (en) Combination for use in the treatment of extra-oesophageal symptoms of gastric reflux
ZA201806894B (en) (+)-azasetron for use in the treatment of ear disorders
PL4009983T3 (en) Cholecalciferol for use in the treatment of celiac disease
EP3713604C0 (en) Compound for use in the increasing of mental capability
GB201809243D0 (en) An unltrasonic system for use in the diagnosis of cancern
GB201706443D0 (en) Device for use in the assessment of peripheral arterial disease
HK40025688A (en) Cobitolimod for use in the treatment of inflammatory bowel disease
GB201616502D0 (en) The use of brain waves as biomarkers for alzheimers disease and combined treatment for early stage diagnosed patients

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)